Studies from Guangdong Medical University Yield New Data on Fatty Liver Disease (ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation)

Press/Media: Press / Media

PeriodJan 11 2023

Media coverage

1

Media coverage

  • TitleStudies from Guangdong Medical University Yield New Data on Fatty Liver Disease (ATL I, Acts as a SIRT6 Activator to Alleviate Hepatic Steatosis in Mice via Suppression of NLRP3 Inflammasome Formation)
    Media name/outletGenomics & Genetics Daily
    Country/TerritoryUnited States
    Date1/11/23
    PersonsHao Chen